Sequence 4 from Patent US 20040043936

General Information


DRACP ID  DRACP01241

Peptide Name   Sequence 4 from Patent US 20040043936

Sequence  CVHAFRA

Sequence Length  7

UniProt ID  Not available

PubChem CID  Not available

Origin  Sos scrofus (Pig)

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01241

Helicity  Not available

Linear/Cyclic  Not available

Disulfide/Other Bond  Not available

N-terminal Modification  Not available

C-terminal Modification  Not available

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C35H54N12O8S

Absent amino acids  DEGIKLMNPQSTWY

Common amino acids  A

Mass  91016

Pl  8.56

Basic residues  2

Acidic residues  0

Hydrophobic residues  4

Net charge  2

Boman Index  -766

Hydrophobicity  77.14

Aliphatic Index  70

Half Life 
  Mammalian: 2.8 hour
  Yeast: 10 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US 2004/0043936 A1

Patent Title  Antiproliferative and antiviral proteins and peptides.

Other Iinformation  Granted Patent Family: 11s / 14ex; Family Jurisdictions: EP, IL, AU, US, AT, DE; Legal Status: Expired; Application No: 67049003; Filed:Sep 25, 2003; Published: Mar 4, 2004; Earliest Priority: Jul 2, 1998; Granted: Jan 13, 2009

Other Published ID  DE69937998D1  DE69937998T2  EP1091753A1  EP1091753A4  EP1091753B1  US7476649 




DRACP is developed by Dr.Zheng's team.